The modulation of interleukin 1 (IL-1) effects on proteoglycan metabolism in intact murine patellar cartilage by transforming growth factor P (TGF-I) was investigated in vitro and in vivo. In vitro TGF-,1 (400 pmol/) had no effect on basal proteoglycan degradation. Proteoglycan degradation induced by IL-1, however, was suppressed by TGF-j in serum free medium alone and in medium supplemented with 0.5 ,ug/mi insulin-like growth factor 1. This suggests a specific regulatory role for TGF-I under pathological conditions. In contrast with the suppression of breakdown, synthesis of proteoglycans was stimulated by TGF-iS for both basal and IL-1 suppressed proteoglycan synthesis in cultures without insulin-like growth factor. In the presence of insulin-like growth factor no extra effect of TGF-(8 on proteoglycan synthesis was observed. With insulin-like growth factor, however, TGF-P potentiated the ex vivo recovery of IL-1 induced suppression of proteoglycan synthesis. Analogous to the in vitro effects, TGF-I8 injected intraarticularly suppressed IL-1 induced proteoglycan degradation. Furthermore, TGF-, injected into the joint counteracted IL-1 induced suppression of proteoglycan synthesis. This indicates that in vivo also TGF-, can ameliorate the deleterious effects of IL-1 on the cartilage matrix.
Many studies have provided evidence for interleukin 1 It has been found that the ubiquitous and multifunctional regulatory peptide transforming growth factor 13 In the present study we investigated TGF-13 modulation of IL-1 effects on proteoglycan degradation and proteoglycan synthesis in intact articular cartilage. We studied this modulation in vitro in basal medium, to confirm earlier studies, '8 19 and in the presence of insulin-like growth factor, which is the major stimulatory factor, with respect to cartilage proteoglycan synthesis, in serum and synovial fluid.33 3 In addition to these more extensive in vitro experiments, we showed for the first time that TGF-1 injected into the joint modulates the effects of IL-1 on proteoglycan metabolism.
Materials and methods

ANIMALS
C57B1/10 mice aged 12 weeks or 18 months were used. They were fed a standard diet and tap water 35 In studies on proteoglycan degradation patellae were prelabelled with [35S] sulphate for three hours and rinsed to remove nonincorporated label before culture with IL-1 and growth factors. Six patellae were placed in 1 ml of incubation medium consisting of RPMI 1640 supplemented with L-glutamine (2 mmolIl), pyruvate (1 mmol/l), and gentamycin (40 pug/ml) at 37°C in a humidified 5% carbon dioxide atmosphere. At the start of the incubation, TGF-1 (10 ng/ml=400 pmol/l) or IL-1 (30 U/ml), or both, were added, alone or in combination with 0.5 ,ug/ml insulin-like growth factor 1. Proteoglycan degradation experiments were stopped after 24 tTGF-13 (400 pmol/l) and IL-1 (30 U) effects were compared with the corresponding controls.
*IL-I plus TGF-P effects were compared with the effects of IL-1 alone. §In cultures without insulin-like growth factor 1 each experimental group consisted of 24 patellae, and in cultures with insulin-like growth factor 1 consisted of 18 patellae.
Modulation ofeffects ofinterleukin 1 on proteoglycan metabolism by TGF-31 safranin 0 staining. Studies using repeated injections of IL-I alone or in combination with TGF-,B are in progress.
Discussion
To study the effects of combinations of cytokine and growth factors on articular cartilage proteoglycan synthesis we cultured anatomically intact patellar cartilage embedded in a minimum area of surrounding tissue.35 Other workers have used sliced cartilage or isolated chondrocytes in the absence of underlying bone and synovial tissue.18 19 40 We used an IL-1 concentration yielding the maximum effects on patellar cartilage proteoglycan metabolism. The chosen TGF-1 concentration (10 ng/ml) has been reported to have an optimum effect on chondrocytes and is physiologically relevant because comparable concentrations of active TGF-1 have been found in arthritic joints.2628 For the first time we tested the effects of TGF-,B in the presence of insulin-like growth factor 1. In an attempt to create a physiologically relevant situation we used an insulin-like growth factor 1 concentration equal to the levels measured in murine serum samples.
We found that in the presence of insulin-like growth factor 1 the spontaneous release of proteoglycan from cultured cartilage was reduced, reaching levels comparable with basal proteoglycan release in vivo.38 39 The protective potency of insulin-like growth factor in cartilage degradation has been reported previously.41A3 Transforming growth factor 1 inhibited IL-1 induced proteoglycan degradation but had no effect on the spontaneously occurring loss of newly formed proteoglycans. In an earlier report describing in vitro TGF-,B effects. on proteoglycan loss from sliced cartilage'9 TGF-,B also inhibited spontaneously occurring proteoglycan loss. The importance of our observation is that for the first time we found evidence indicating that TGF-,B modulation of IL-1 induced proteoglycan degradation is specific, independent of TGF-1 effects on basal degradation. Possibly IL-1 induces a separate set of proteases, different from the proteases taking part in normal turnover, that can be modulated specifically by TGF-1. Whether TGF-1 mainly influences the production of proteases or protease inhibitors32 [44] [45] [46] remains to be investigated.
Another possible mechanism for specific TGF-1 modulation of IL-1 induced proteoglycan degradation could be that TGF-P, in contrast with other growth factors, downregulates IL-1 receptor expression. 7 47 Induction of an IL-1 receptor antagonist protein by TGF-1 in peripheral blood monocytes has also been reported.48
The only previous report describing the effects of TGF-1 on proteoglycan synthesis in articular cartilage was that by Morales and Roberts.40 They used long term cultures of sliced bovine cartilage. In our studies we cultured for only two days, the time necessary to obtain a maximum IL-I effect on proteoglycan synthesis. Again, the presence of insulin-like growth factor appeared to be important for stabilisation of proteoglycan metabolism in our patellae culture system. In the absence of insulin-like growth factor, TGF-1 (400 pmol/l, 48 hours) stimulated both IL-1 suppressed and spontaneously occurring proteoglycan synthesis. Chandrasekhar and Harvey"8 found the same trend in monolayers of articular chondrocytes. In earlier studies performed in our laboratory,43 TGF-(0-200 pmol/l) was found to have no effect on proteoglycan synthesis in short term experiments. In addition, also in vivo, we saw no effect of TGF-13 on basal proteoglycan synthesis 24 
